Vanda Pharmaceuticals Inc (VNDA)

Nov 03, 2025

Will Vanda Pharmaceuticals Inc. (VM4) stock see insider accumulationIndex Update & Advanced Swing Trade Entry Plans - newser.com

Nov 03, 2025

Nov 03, 2025

Will Vanda Pharmaceuticals Inc. stock benefit from infrastructure spendingJuly 2025 News Drivers & Smart Money Movement Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

How supply shortages influence Vanda Pharmaceuticals Inc. (VM4) stockJuly 2025 EndofMonth & Reliable Trade Execution Plans - newser.com

Nov 03, 2025

Nov 03, 2025

Visualizing Vanda Pharmaceuticals Inc. stock with heatmapsWeekly Market Summary & Advanced Technical Analysis Signals - newser.com

Nov 03, 2025

Nov 03, 2025

Is Vanda Pharmaceuticals Inc. stock safe for conservative investorsWeekly Profit Analysis & AI Powered Market Entry Strategies - newser.com

Nov 03, 2025

Nov 03, 2025

Will Vanda Pharmaceuticals Inc. stock recover after recent drop2025 Support & Resistance & Growth Focused Stock Pick Reports - newser.com

Nov 03, 2025

Nov 03, 2025

How Vanda Pharmaceuticals Inc. stock performs in interest rate cycles2025 Top Decliners & Smart Swing Trading Techniques - newser.com

Nov 03, 2025

Nov 03, 2025

Can Vanda Pharmaceuticals Inc. stock deliver surprise earnings beatWeekly Trade Report & High Yield Equity Trading Tips - newser.com

Nov 03, 2025

Nov 03, 2025

Backtesting results for Vanda Pharmaceuticals Inc. trading strategiesQuarterly Trade Report & Proven Capital Preservation Methods - newser.com

Nov 03, 2025

Nov 03, 2025

Smart tools for monitoring Vanda Pharmaceuticals Inc.’s price action2025 Key Lessons & Safe Entry Trade Signal Reports - newser.com

Nov 03, 2025

Nov 03, 2025

Can Vanda Pharmaceuticals Inc. recover in the next quarterMarket Activity Report & Fast Moving Stock Watchlists - newser.com

Nov 03, 2025

Nov 03, 2025

Will Vanda Pharmaceuticals Inc. (VM4) stock remain on Wall Street radar2025 Market Outlook & Daily Stock Trend Watchlist - newser.com

Nov 03, 2025

Nov 03, 2025

FY2025 EPS Estimates for VNDA Boosted by Cantor Fitzgerald - MarketBeat

Nov 03, 2025

Nov 02, 2025

News impact scoring models applied to Vanda Pharmaceuticals Inc.Portfolio Update Summary & Free Fast Gain Swing Trade Alerts - newser.com

Nov 02, 2025

Nov 02, 2025

Is Vanda Pharmaceuticals Inc. (VM4) stock considered safe havenMarket Trend Report & Capital Efficiency Focused Strategies - newser.com

Nov 02, 2025

Nov 02, 2025

Assessing Vanda Pharmaceuticals (VNDA) Valuation After Q3 2025 Growth and Updated FDA Milestones - Yahoo Finance

Nov 02, 2025

Nov 02, 2025

How institutional buying supports Vanda Pharmaceuticals Inc. stock2025 Top Decliners & Smart Swing Trading Techniques - newser.com

Nov 02, 2025

Nov 02, 2025

Vanda Pharmaceuticals (NASDAQ:VNDA) Upgraded by Wall Street Zen to Hold Rating - MarketBeat

Nov 02, 2025

Oct 31, 2025

Vanda Pharmaceuticals Reports Strong Sales Growth and Pipeline Progress - MSN

Oct 31, 2025

Oct 31, 2025

Cantor Fitzgerald Cuts Vanda Pharmaceuticals (NASDAQ:VNDA) Price Target to $11.00 - MarketBeat

Oct 31, 2025

Oct 31, 2025

Jim Cramer on Vanda Pharmaceuticals: “I’m Going to Bless That One as Your Spec” - MSN

Oct 31, 2025

Oct 31, 2025

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q3 2025 Earnings Call Transcript - Insider Monkey

Oct 31, 2025

Oct 31, 2025

Vanda Pharmaceuticals Q3 Earnings Preview - MSN

Oct 31, 2025

Oct 31, 2025

Published on: 2025-10-31 05:46:53 - newser.com

Oct 31, 2025

Oct 31, 2025

Applying big data sentiment scoring on Vanda Pharmaceuticals Inc.2025 Growth vs Value & Low Risk Profit Maximizing Plans - newser.com

Oct 31, 2025

Oct 31, 2025

Real time pattern detection on Vanda Pharmaceuticals Inc. stockQuarterly Profit Review & Consistent Return Strategy Ideas - newser.com

Oct 31, 2025

Oct 31, 2025

Vanda Pharmaceuticals Inc. stock retracement – recovery analysis - newser.com

Oct 31, 2025

Oct 31, 2025

Vanda Pharmaceuticals (VNDA): Forecasts See Earnings Growth of 68.5% Annually Heading Into Earnings Season - Sahm

Oct 31, 2025

Oct 30, 2025

Vanda Pharmaceuticals (VNDA): Revenue Projected to Grow 22.7% Annually, Profitability in Focus Ahead of Earnings - Yahoo Finance

Oct 30, 2025

Oct 30, 2025

Vanda Pharmaceuticals Inc (VNDA) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... By GuruFocus - Investing.com Canada

Oct 30, 2025

Oct 30, 2025

Vanda Pharmaceuticals Inc. (VNDA) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK

Oct 30, 2025

Oct 30, 2025

Vanda Pharmaceuticals (NASDAQ:VNDA) Posts Quarterly Earnings Results, Hits Estimates - MarketBeat

Oct 30, 2025

Oct 30, 2025

Vanda Pharmaceuticals Inc (VNDA) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid Rising Expenses - GuruFocus

Oct 30, 2025

Oct 30, 2025

VNDA Analyst Rating Update: Cantor Fitzgerald Adjusts Price Target | VNDA Stock News - GuruFocus

Oct 30, 2025

Oct 30, 2025

Vanda Pharmaceuticals Inc. SEC 10-Q Report - TradingView

Oct 30, 2025

Oct 30, 2025

Vanda Sees Sales Jump, But Losses Also Pile Up - Finimize

Oct 30, 2025